Asklepios BioPharma Launches New Biotech Actus Therapeutics Post author:Sam Post published:December 14, 2017 Post category:BioPharma Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics. Source: BioSpace You Might Also Like German Biotech InflaRx Snags $100M in IPO November 8, 2017 Bio-Rad Reports Fourth-Quarter And Full-Year 2016 Financial Results February 23, 2017 Bay Area's Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen December 5, 2017
